MEDEXUS PHARMACEUTICALS INC (MDP.CA) Stock Balance Sheet
TSX:MDP • CA58410Q2036
Current stock price
3.14 CAD
+0.11 (+3.63%)
Last:
| MRQ (2025-12-31) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 14.97M | 23.97M | 5.25M | 13.07M | 10.02M | |||
| Receivables | 11.83M | 13.31M | 24.03M | 22.38M | 14.41M | |||
| Inventories | 31.30M | 35.29M | 30.77M | 22.85M | 21.35M | |||
| Other Current Assets | 11.86M | 8.00M | 12.44M | 14.67M | 3.33M | |||
| Total Current Assets | 69.97M | 80.57M | 72.50M | 72.97M | 49.11M | |||
| Non-Current Assets | ||||||||
| PPE Net | 457.00K | 689.00K | 778.00K | 899.00K | 1.22M | |||
| Goodwill | 10.22M | 10.00M | 10.28M | 10.28M | 10.69M | |||
| Intangibles | 64.78M | 71.60M | 64.14M | 70.37M | 76.56M | |||
| Other Non-Current Assets | 9.56M | 8.98M | 8.04M | 6.81M | 1.64M | |||
| Total Non-Current Assets | 85.02M | 91.27M | 83.24M | 88.36M | 90.11M | |||
| TOTAL ASSETS | 154.98M | 171.84M | 155.73M | 161.33M | 139.22M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 7.20M | 36.98M | 15.74M | 42.71M | 15.05M | |||
| Accrued Expenses | N/A | 35.29M | 35.48M | 23.26M | 17.13M | |||
| Accounts Payable | 43.38M | 5.73M | 7.75M | 10.16M | 12.05M | |||
| Other Current Liabilities | 11.82M | 19.31M | 7.25M | 7.38M | 3.89M | |||
| Total Current Liabilities | 62.40M | 97.31M | 66.23M | 83.50M | 48.11M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 18.15M | 198.00K | 34.15M | 27.38M | 39.82M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 1.52M | |||
| Other Non-Current Liabilities | 22.22M | 22.19M | 25.03M | 28.01M | 31.99M | |||
| Total Non-Current Liabilities | 40.37M | 22.39M | 59.18M | 55.38M | 73.33M | |||
| TOTAL LIABILITIES | 102.77M | 119.69M | 125.41M | 138.88M | 121.43M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -61.71M | -61.99M | -64.24M | -64.03M | -65.25M | |||
| Additional Paid In Capital | 11.55M | 12.01M | 12.01M | 11.31M | 10.38M | |||
| Common Shares | 96.22M | 96.10M | 76.39M | 69.01M | 68.69M | |||
| Other Shareholders' Equity | 6.15M | 6.03M | 6.17M | 6.16M | 3.97M | |||
| Shares Outstanding | 32.31M | 32.26M | 24.46M | 20.18M | 19.95M | |||
| Tangible Book Value per Share | -0.71 | -0.91 | -1.80 | -2.88 | -3.48 | |||
| Total Shareholders' Equity | 52.21M | 52.14M | 30.32M | 22.45M | 17.79M | |||
| TOTAL LIABILITIES AND EQUITY | 154.98M | 171.84M | 155.73M | 161.33M | 139.22M | |||
| Statistics | ||||||||
| Debt/Equity | 0.35 | 0.00 | 1.13 | 1.22 | 2.24 | |||
| Current Ratio | 1.12 | 0.83 | 1.09 | 0.87 | 1.02 | |||
| Return On Assets (ROA) | -0.18% | 1.31% | -0.14% | 0.76% | -2.07% | |||
| Return On Equity (ROE) | -0.52% | 4.31% | -0.71% | 5.44% | -16.18% | |||
| Return On Invested Capital (ROIC) | 3.02% | 11.52% | 10.29% | 7.85% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 3.61% | 16.98% | 10.93% | 9.44% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 107.26% | N/A | 93.64% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.28